BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Japan and CareNet of Japan participated in the round, as did existing investors including Mitsubishi UFJ Capital...
BioCentury | Mar 9, 2020
Finance

With $22M B round, Numab to build out multispecific mAb pipeline

...additional CHF7 million ($7.1 million), bringing the round to CHF22 million. New investors included Mitsubishi UFJ Capital...
BioCentury | Jun 22, 2018
Finance

Regenerating eastward

...round, which closed in 2016, included three additional Asian funders -- Japanese VC firms Mitsubishi UFJ Capital...
BioCentury | Mar 30, 2018
Company News

Daiichi, UFJ, Japanese universities launch hyperthermia newco

...Daiichi Sankyo Co. Ltd. (Tokyo:4568), Mitsubishi UFJ Capital Co. Ltd. (Tokyo, Japan), Nagoya City University and Chubu...
...any resulting products. OiDE RYO-UN Inc., Tokyo, Japan Business: Cancer Elizabeth S. Eaton Daiichi Sankyo Co. Ltd. Mitsubishi UFJ Capital...
BioCentury | Feb 8, 2018
Finance

External rethink

...that time. In the same period, two companies -- Daiichi Sankyo Co. Ltd. and Mitsubishi UFJ Capital...
...Massachusetts Institute of Technology (MIT), Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Mitsubishi UFJ Capital...
...Ltd. Innovative Medicines Initiative (IMI) Japan Agency for Medical Research and Development Johnson & Johnson Massachusetts Institute of Technology Mitsubishi UFJ Capital...
BioCentury | Nov 9, 2017
Finance

The return of big

...research center with the National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN) and Mitsubishi UFJ Capital...
...Molecular Physiology, Dortmund, Germany Max Planck Society, Munich, Germany Merck KGaA (Xetra:MRK), Darmstadt, Germany Mitsubishi UFJ Capital...
...Hospital Dana-Farber Cancer Institute Eli Lilly and Co. Indiana University Johnson & Johnson Lead Discovery Center GmbH Max Planck Society Merck KGaA Mitsubishi UFJ Capital...
BioCentury | Oct 13, 2017
Financial News

DiscGenics raises $14M in series B

...jointly led by the company’s board of directors, new and existing investors and observer Mitsubishi UFJ Capital...
BioCentury | Jul 7, 2017
Financial News

Anaeropharma raises $13.2M

...Seventure Partners’ Health for Life Capital. Existing investors Innovation Network Corp. of Japan and Mitsubishi UFJ Capital...
BioCentury | Jul 5, 2017
Financial News

Microbiome company Anaeropharma raises $13.2M

...Seventure Partners’ Health for Life Capital. Existing investors Innovation Network Corp. of Japan and Mitsubishi UFJ Capital...
BioCentury | Mar 30, 2017
Finance

Mitsubishi the matchmaker

...With a second dedicated life sciences fund, Mitsubishi UFJ Capital Co. Ltd. plans to promote partnerships and...
...to purchase the company's stock or IP at a preset price. Virginia Li, Staff Writer Mitsubishi UFJ Capital Mitsubishi UFJ Capital...
Items per page:
1 - 10 of 33
BioCentury | Aug 26, 2020
Deals

Aug. 25 Quick Takes: A slew of private financings led by Connect’s $115M series C; plus BMS-Forbius, Takeda deals, Bio-Thera-BeiGene and adds to HKSE, NASDAQ queues

...Japan and CareNet of Japan participated in the round, as did existing investors including Mitsubishi UFJ Capital...
BioCentury | Mar 9, 2020
Finance

With $22M B round, Numab to build out multispecific mAb pipeline

...additional CHF7 million ($7.1 million), bringing the round to CHF22 million. New investors included Mitsubishi UFJ Capital...
BioCentury | Jun 22, 2018
Finance

Regenerating eastward

...round, which closed in 2016, included three additional Asian funders -- Japanese VC firms Mitsubishi UFJ Capital...
BioCentury | Mar 30, 2018
Company News

Daiichi, UFJ, Japanese universities launch hyperthermia newco

...Daiichi Sankyo Co. Ltd. (Tokyo:4568), Mitsubishi UFJ Capital Co. Ltd. (Tokyo, Japan), Nagoya City University and Chubu...
...any resulting products. OiDE RYO-UN Inc., Tokyo, Japan Business: Cancer Elizabeth S. Eaton Daiichi Sankyo Co. Ltd. Mitsubishi UFJ Capital...
BioCentury | Feb 8, 2018
Finance

External rethink

...that time. In the same period, two companies -- Daiichi Sankyo Co. Ltd. and Mitsubishi UFJ Capital...
...Massachusetts Institute of Technology (MIT), Cambridge, Mass. Merck & Co. Inc. (NYSE:MRK), Kenilworth, N.J. Mitsubishi UFJ Capital...
...Ltd. Innovative Medicines Initiative (IMI) Japan Agency for Medical Research and Development Johnson & Johnson Massachusetts Institute of Technology Mitsubishi UFJ Capital...
BioCentury | Nov 9, 2017
Finance

The return of big

...research center with the National Institutes of Biomedical Innovation Health and Nutrition (NIBIOHN) and Mitsubishi UFJ Capital...
...Molecular Physiology, Dortmund, Germany Max Planck Society, Munich, Germany Merck KGaA (Xetra:MRK), Darmstadt, Germany Mitsubishi UFJ Capital...
...Hospital Dana-Farber Cancer Institute Eli Lilly and Co. Indiana University Johnson & Johnson Lead Discovery Center GmbH Max Planck Society Merck KGaA Mitsubishi UFJ Capital...
BioCentury | Oct 13, 2017
Financial News

DiscGenics raises $14M in series B

...jointly led by the company’s board of directors, new and existing investors and observer Mitsubishi UFJ Capital...
BioCentury | Jul 7, 2017
Financial News

Anaeropharma raises $13.2M

...Seventure Partners’ Health for Life Capital. Existing investors Innovation Network Corp. of Japan and Mitsubishi UFJ Capital...
BioCentury | Jul 5, 2017
Financial News

Microbiome company Anaeropharma raises $13.2M

...Seventure Partners’ Health for Life Capital. Existing investors Innovation Network Corp. of Japan and Mitsubishi UFJ Capital...
BioCentury | Mar 30, 2017
Finance

Mitsubishi the matchmaker

...With a second dedicated life sciences fund, Mitsubishi UFJ Capital Co. Ltd. plans to promote partnerships and...
...to purchase the company's stock or IP at a preset price. Virginia Li, Staff Writer Mitsubishi UFJ Capital Mitsubishi UFJ Capital...
Items per page:
1 - 10 of 33